These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1455400)

  • 21. Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.
    Yoshida N; Okuma M; Hirata H; Matsuda M; Yamazumi K; Asakura S
    Blood; 1991 Jul; 78(1):149-53. PubMed ID: 2070049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An apparently higher molecular weight gamma-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of gamma arginine-275 by cysteine.
    Yoshida N; Ota K; Moroi M; Matsuda M
    Blood; 1988 Feb; 71(2):480-7. PubMed ID: 3337908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
    Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I
    Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B; Lord ST; Furlan M
    Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
    Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
    Brennan SO; Hammonds B; George PM
    J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain.
    Uotani C; Miyata T; Kumabashiri I; Asakura H; Saito M; Matsuda T; Kajiyama S; Iwanaga S
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):413-7. PubMed ID: 1932527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
    Lounes KC; Lefkowitz JB; Coates AI; Hantgan RR; Henschen-Edman A; Lord ST
    Ann N Y Acad Sci; 2001; 936():129-32. PubMed ID: 11460470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis.
    Yoshida N; Hirata H; Morigami Y; Imaoka S; Matsuda M; Yamazumi K; Asakura S
    J Biol Chem; 1992 Feb; 267(4):2753-9. PubMed ID: 1733971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
    Webb CD; Hantgan RR; Byeff PD; Owen J
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His).
    Siebenlist KR; Mosesson MW; Di Orio JP; Tavori S; Tatarsky I; Rimon A
    Thromb Haemost; 1989 Nov; 62(3):875-9. PubMed ID: 2512677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
    Krajewski T; Nowak P; Cierniewski C
    Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
    Seydewitz HH; Gram J; Bruhn HD; Witt I
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
    Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
    Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
    Meyer M; Bergmann F; Brennan SO
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates.
    Lord ST; Strickland E; Jayjock E
    Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
    Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
    Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.